CATALYST FOR CHANGE IN CANCER CARE
MANAGING INNOVATION IN ONCOLOGY
05.
CATALYSTS FOR CHANGE IN CANCER CARE
the next decade in healthcare will look nothing like the last- oncology is experiencing a tidal wave of therapies and technologies that continues to profoundly change the way cancer is diagnosed, treated, and monitored. the arrival of novel and disruptive technologies, precision medicine and emerging technologies, will drive oncology onward and the decisions taken today will have an impact on the landscape over the next decade. industry, regulators, HTA, pricing agencies, health care professionals, researchers and patient advocates must work together to address these challenges and create solutions to overcome these clinical, regulatory, reimbursement and policy hurdles.
as innovations continue to profoundly change the way cancer care is organized and delivered across canada, and globally our goal is to start thinking about these unique challenges now, proactively, so we are better prepared to respond, embrace and implement further disruptive innovations as they continue to make their way in the cancer ecosystem.
blog posts
improving access to innovative therapies
here's how biologics have become an important part in the cancer landscape, providing better outcomes for some patients . because they are made from living organisms biologics can not be exactly copied [generics]. the complex manufacturing process of biologics results...
precision medicine awareness month launches in canada
throughout the month of november, the cancer collaborative in collaboration with the european cancer patients coalition [ECPC] will highlight the growing role that precision medicine plays in oncology through the CRACKING THE CANCER CODE campaign. the premise of...
ASCO 20 – UNITE AND CONQUER TO ACCELERATE PROGRESS TOGETHER
for the first time since its inception in 1965, the ASCO scientific conference was held virtually amid the COVID 19 pandemic. this did not stop the global oncology community from convening during three days [from may 29-31] to accelerate progress together. on june 4th...
#travelwithcolab
this year promises to be another filled with interesting conversations, dynamic dialogues and learning, lots of learning - across the globe. learning from different experiences, various perspectives, understanding how things are done outside of canada and taking those...
ASCO 2020 clinical advances of the year
ASCO has published their annual report on progress against cancer - the report highlights the most important clinical research advances of the past year and identifies priority areas where ASCO believes research efforts should focus moving forward. this year the...
biosimilars can significantly reshape access to innovative cancer therapies
world cancer day #iamandiwill
this year marks the 20th celebration of world cancer day - it began with six cancer experts who convened in paris in 1999. with the year 2000 imminent, the group was determined that the global challenge of cancer would not be forgotten in the new century. as we...
can real world evidence [RWE] really transform healthcare
with a growing burden of disease, an ageing population, increased cost and capacity challenges, and increasing drug prices- there is an urgent need to remove inefficiencies to improve the delivery of care and patient outcomes. real world evidence could significantly...
canadian institute for health information [CIHI] publishes drug spending statistics
last december, the canadian institute for health information published statistics on drug spending, finding that in 2018 approximately 40% of drug spending was spent on 2% of beneficiaries. of this 2%, three out of five individuals used a drug therapy that cost...
the future of healthcare is personalized.
rapid advances of the molecular pathways that underlie cancer combined with an expansion of the tools at our disposal to diagnose and treat based on these specific genomic features has paved the way for precision medicine in cancer and other diseases. and as we...
